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Abstract
Introduction: We compared the postoperative sexual function of 
patients who underwent wide local excision (WLE) and glansec-
tomy with urethral glanduloplasty for penile cancer.
Methods: We retrospectively reviewed clinical data of 41 patients 
affected by superficial, localized penile cancer (≤cT2a) between 
2006 and 2013. Patients with severe erectile dysfunction and not 
interested in resuming an active sexual life were selected for penile 
partial amputation. Patients with preoperative satisfying erectile 
function and concerned about the preservation of their sexual 
potency were scheduled for WLE (Group A) or glansectomy with 
urethral glanduloplasty (Group B). Sexual function was assessed 
with the International Index of Erectile Function (IIEF) question-
naire and the Sex Encounter Profile (SEP). At 1 year, patients were 
asked to complete the questionnaires again and were questioned 
about their genital sensibility and ejaculatory reflex persistence. 
Postoperative complications were reported according to the 
Clavien-Dindo classification. Statistical analysis was performed 
by two-tailed test: Student t-test and chi-square.
Results: Among the 41 patients enrolled, 12 underwent WLE 
(29.2%), 23 glansectomy with urethral glanduloplasty (56%) and 
6 with penile partial amputation (14.6%). A decrease in postop-
erative IIEF was recorded in both groups, but was statistically sig-
nificant only in Group B (p = 0.003). As for the SEP, while no 
significant changes were recorded postoperatively in Group A, a 
marked reduction was reported for Group B, with a statistically 
significant decrease in the possibility of achieving penetrative inter-
course (p = 0.006) and in the perceived satisfaction during sexual 
activity (p = 0.004).
Conclusions: WLE lead to better sexual outcomes and less postop-
erative complications as compared to glansectomy with urethral 
glanduloplasty.
Introduction 
Penile cancer affects less than 1/100 000 in Western coun-
tries1,2 and is a severe health problem in developing countries 
where its incidence can be up to five times higher.3 Excellent 
oncological results can be achieved with radical approach-
es, in spite of a devastating impact on patient quality of life 
and sexual function.4-7 Historically, the primary tumour has 
been surgically treated with demolitive technique, such as 
partial or total amputation. A standard 2-cm free margin was 
believed necessary to achieve excellent oncologic results.8 
However, according to recent evidence, only few millime-
ters of tumour-free tissue is sufficient to consider surgical 
margins as negative.9-11 Following this lead, the last update 
of the European Association of Urology (EAU) guidelines 
suggest a 5-mm margin to achieve the oncological safety 
in penile-sparing surgery.12 Consequently, penile-sparing 
approaches have been increasingly employed, with excel-
lent functional outcomes and significant improvements in 
patients’ quality of life compared to radical treatment.13-18 
Radical procedures are now reserved in selected cases, such 
as advanced local tumours or recurrence after organ-sparing 
surgery. On the other hand, conservative procedures, such 
as glansectomy with urethral glanduloplasty and primary 
lesion wide local excision (WLE), are considered the gold 
standard for T1, T2 and selected T3 tumours.12
Only few comparative data have been published about 
postoperative sexual function in patients who underwent 
demolitive and conservative penile procedures. In this study, 
we evaluated the postoperative sexual function of patients 
who underwent two different conservative approaches for 
penile cancer: WLE and glansectomy with urethral glan-
duloplasty. To our knowledge, this is the first comparative 
study to specifically focus on the sexual function after such 
delicate procedures.
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Methods 
We retrospectively reviewed the records of 49 patients eval-
uated in our urology department for a primary penile cancer 
between 2006 and 2013. Among these, we selected those 
affected by superficial, localized penile cancer (≤cT2a), with 
non-palpable inguinal nodes and negative node sentinel 
biopsy. We excluded those positive to the sentinel node 
biopsy (n = 8) and those who received a modified monolat-
eral inguinal lymph node dissection to avoid bias in terms 
of either oncological and functional outcomes.4 Adhering 
to EAU guidelines,12 we planned the surgical treatments. 
Patients with preoperative satisfying erectile function and 
concerned about the preservation of their sexual potency 
were scheduled for WLE (Group A) or glansectomy with 
urethral glanduloplasty (Group B), according to tumour char-
acteristics. Patients with severe erectile dysfunction and not 
interested in resuming an active sexual life were selected 
for penile partial amputation without glans reconstruction, 
favouring oncologic safety (Group C). In particular, patients 
with single lesions <1.5 cm underwent WLE. Patients with 
contrast lesions >1.5 cm or multiple glans lesions underwent 
a glansectomy. A frozen section examination during the 
surgical procedure was performed in all cases to confirm 
safe surgical margins. 
At the preoperative visit, a careful examination excluded 
the infiltration of the corpora cavernosa or the urethra and 
we evaluated the status of the inguinal nodes. The stretched 
length of the penis was measured and sexual function was 
assessed by the International Index of Erectile Function (IIEF) 
questionnaire19 and the Sex Encounter Profile (SEP-2, SEP-3).20
At the 1 year follow-up, patients were asked to com-
plete the questionnaires again and were questioned about 
their genital sensibility and the ejaculatory reflex persis-
tence. The postoperative length of the shaft was measured. 
Postoperative complications were reported according to 
the Clavien-Dindo classification.21 Statistical analysis was 
performed by two-tailed paired samples Student T-test and 
chi-square or their non-parametric counterparts, using IBM 
SPSS Statistics Software version 20.
Results 
We tallied baseline patient characteristics (Table 1). 
One patient scheduled for WLE of a 1.5 cm glans lesion 
had a positive surgical margin at the definitive histological 
examination, managed with a second stage glansectomy 
with urethralglanduloplasty. This patient, initially belonging 
to Group A, was excluded for the evaluation of functional 
outcomes. Another patient who had undergone WLE (T1b 
penile cancer with negative margins) developed local recur-
rence after 25 months, and was managed with a glansectomy 
with urethral glanduloplasty. Concerning the length of the 
stretched penis, Groups A and B were comparable in terms 
of preoperative measures, such as age, preoperative IIEF-15 
and SEP 2-3 (p = 0.08). However, a sharp decrease of penile 
length was noted in patients undergoing glansectomy with 
urethral glanduloplasty (Group B), with an average decrease 
of 3.5 cm (range: 2.5–5) (p = 0.001). Even if a decrease in 
postoperative IIEF was recorded in both groups, it was sta-
tistically significant only in Group B (p = 0.003) (Table 2). 
As for the SEP, many patients in both groups reported 
allowed (SEP-2) and satisfactory (SEP-3) intercourse pre-
operatively. While no significant changes were recorded 
postoperatively in Group A, a marked reduction of SEP-2 
and SEP-3 was reported for Group B, with a decrease in the 
possibility of achieving penetrative intercourse (p = 0.006) 
and in the perceived satisfaction during sexual activity 
(p = 0.004). Finally, we analyzed two major aspects con-
cerning patient sexual functions: the genital sensitivity level 
and the presence of an ejaculatory reflex after appropriate 
stimulation (Table 3).
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Table 1. Baseline patients characteristics
Group A (n = 12) Group B (n = 23) Group C (n = 6) Total (n = 41) p value
Mean age, years 56 (28–72) 60 (45–68) 73 (62–92) 63 (28–92) 0.09
Penile stretched length, cm 12.6 (8.8-16) 13.8 (8–17.5) 12.8 (8.2–16.5) 12.9 (8–17.5) 0.08
pT Stage
T1 8 10 2 20
T2 4 13 4 21
Hospital stay, days 5 (4–7) 6 (4–8) 8 (5–15) 6.5 (4–15) 0.06
Complications
Clavien 1–2 0 0 1 1 0.08
Clavien 3 0
3 (meatal 
stenosis)
0 3 0.06
Positive margins 1 0 0 1 0.07
Recurrence 1 0 0 1 0.07
Mean follow-up, months 33 (16–45) 36 (20–50) 23 (18–52) 34 (16–52) 0.08
Disease free at last follow-up, months 12 23 6 41 0.07
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In Group A, an unmodified postoperative genital sensi-
bility was recorded, with ejaculatory reflex preservation in 
75% of cases; on the other hand, Group B had a reduction 
of genital sensibility in 59.1% of patients, with 9.1% of 
patients reporting total absence of erogenous sensations. The 
ejaculatory reflex was preserved in 68.2% of cases.
Discussion 
Penile cancer is rare in western countries. The EAU has 
recently published guidelines for its management,12 although 
a standardized approach is still lacking. Historically, total and 
partial penectomy have been widely employed, with a 2-cm 
healthy tissue margin to assure good oncologic outcome.8 
However, significant functional and psychological issues 
are encountered with radical approaches. D’Ancona and 
colleagues investigated the impact of partial penectomy on 
quality of life in a series of 14 penile cancer patients, report-
ing a satisfying quality of life in all patients and a preserved 
sexual function only in 64% of cases.5 More recently, Romero 
and colleagues showed a statistically significant reduction of 
erectile function and sexual satisfaction after partial penec-
tomy. This was attributed to the sensible reduction of penile 
size and glans removal, leading to an important feeling of 
shame about the penis. In their series, only 33% of patients 
maintained their preoperative sexual intercourse frequency 
and were satisfied with their sexual life.6 
The evidence for achieving 2-cm free margins is unknown. 
Recently, several authors have stated that a few millimeters 
of healthy tissue are sufficient and do not jeopardize pri-
mary oncologic control. In 1999, Hoffman and colleagues 
were the first to suggest that local control could be achieved 
with surgical margins <2 cm, analyzing the outcomes of 7 
patients who had undergone partial penectomy with surgi-
cal margins <10 mm – none of these patients experienced 
local recurrence.9 More recently, a histopatological review 
on 102 surgical margins confirmed that few millimeters of 
healthy margins are enough to achieve excellent oncologi-
cal results after conservative surgery for penile cancer.10 
The same conclusions were reached by Philippou and col-
leagues, who concluded that penile conserving surgery is 
oncologically safe and a surgical excision margin of less 
than 5 mm is adequate. Notably, local recurrence did not 
negatively affect long-term survival.18 These findings were 
successfully confirmed by Djajadiningrat and colleagues, 
who observed a higher local recurrence rate after conser-
vative surgery (41% vs. 29%), but with no effect on 5-year 
cancer-specific survival (CSS).22 All these considerations 
were confirmed in our study, where a 5-mm healthy tissue 
was enough to achieve remarkable oncologic outcomes. 
The only positive margin was found after WLE, and was 
successfully managed after a second surgery. The only local 
recurrence, experienced a few years after WLE, was again 
successfully managed with no impacts on CSS to date. As 
sexual function after surgery for penile cancer
Table 2. The International Index of Erectile Function (IIEF)-15 
IIEF Domains
Group A
Preoperative
Group A
Postoperative
p value
Group B
Preoperative
Group B
Postoperative
p value
Erectile function
score (1–30)
17.2 (15–22)
Mild to moderate
16.5 (13–21)
Mild to moderate
0.3
19 (16–25)
Mild
15.7 (13–19)
Mild to moderate
0.012
Orgasmic function
score (0–10)
6 (2–8)
Mild to moderate
5.3 (3–8)
Mild to moderate
0.25
6 (2–7)
Mild to moderate
4.8 (1–6)
Moderate
0.04
Sexual desire
score (2–10)
7.2 (5–9)
Mild
6.4 (4–8)
Mild to moderate
0.15
7.2 (5–9)
Mild
6 (2–7)
Mild to moderate
0.8
Intercourse satisfaction
score (0–15)
9.3 (7–13)
Mild to moderate
8.2 (5–11)
Mild to moderate
0.09
9 (4–12)
Mild to moderate
7 (3–10)
Mild to moderate
0.12
Overall satisfaction
score (2–10)
6 (5–9)
Mild to moderate
4.5 (2–6)
Moderate
0.25
7.3 (4–9)
Mild
3.6 (2–5)
Moderate
0.01
Total (5–75) 45.7 40.9 0.08 48.5 37.1 0.003
Table 3. Sex encounter profile, genital sensitivity and ejaculatory reflex
Domains
Group A
Preoperative
Group A
Postoperative
p value
Group B
Preoperative
Group B
Postoperative
p value
SEP-2 
(positive answer)
75% 75% >0.05 86.4% 59.1% 0.006
SEP-3
(positive answer)
75% 62.5% 0.09 71% 31.8% 0.004
Genital sensivity 75% 62.5% 0.09 71% 31.8% 0.004
Preserved ejaculatory reflex 100% 100% Unmodified >0.05 100%
31.8% Unmodified
59.1% Reduced
9.1% Absent
0.003
SEP: Sex encounter profile.
we expected, WLE had a slightly higher risk of local recur-
rence as compared to glansectomy. 
Conservative approaches are superior in terms of func-
tional and cosmetic outcomes, while maintaining an ade-
quate oncologic safety. Organ-sparing surgery preserves 
penile length and shape, with satisfying recovery of the 
sexual function and acceptable  psychological repercus-
sions, while not jeopardizing oncological safety.14,23
Even the recent update of EAU guidelines underlined 
the need of as much organ preservation as possible, while 
removing the primary penile lesion.12 As an alternative to 
radical approaches, several surgeons have employed tech-
niques of glansectomy without glans reconstruction with 
acceptable aesthetic results.15 In 2007 Palminteri and col-
leagues reported their experience in glansectomy associated 
to glans reconstruction by a skin graft harvested from the 
thigh after penile cancer. Skin reconstruction led to excel-
lent functional and aesthetic outocomes without jeopardiz-
ing cancer control.16 WLE plus primary closure of the glans 
is another penile-sparing option, which is oncologically 
safe with the benefits of a maximally conservative proce-
dure.17 Since 2006, we have performed two penile-sparing 
approaches: WLE with primary closure without grafting and 
glansectomy with urethralglanduloplasty. Notably, no recent 
studies have compared different conservative approaches of 
penile cancer in terms of sexual outcomes.
We found that WLE achieved the best results in terms of 
postoperative sexual function compared with glansectomy 
with urethral glanduloplasty. This conservative procedure 
did not affect erectile function or future penetrative inter-
course, whereas glansectomy affected both these domains. 
In particular, erectile function, orgasmic function, and over-
all satisfaction were the most affected domains after glansec-
tomy. WLE was superior in terms of postoperative erectile 
function, as it preserved the anatomical structures giving 
the penis the necessary rigidity for penetration, and sensi-
bility for satisfactory intercourse. These results have been 
strongly confirmed in our study by the IIEF and SEP scores. 
Glansectomy with urethral glanduloplasty is an organ-spar-
ing approach which can lead to satisfactory aesthetic and 
functional results. However, the complete removal of the 
glans is a strong drawback, as it reduces patient sensibility 
during the intercourse. The glans reconstruction with the 
urethra provides genital sensation which is not comparable 
to the original one. On the other hand, the negative impact 
of the erectile function can be explained by the penile short-
ening as demonstrated by our study, leading to difficult vagi-
nal penetration, and the strong psychological consequences 
of the glans removal. Our results are in contrast with the 
study by Gulino and colleagues,23 which reported no dif-
ferences in postoperative IIEF score, ejaculation or orgasm 
activity in a series of 14 patients undergoing glansectomy 
with urethral glanduloplasty. 
A final aspect involves postoperative complications. In 
our hands, all the techniques were safe with no major com-
plications. WLE was superior to glansectomy in terms of 
overall complications, as three cases of meatal stenosis were 
reported after the latter procedure. 
Our results must be balanced against the limits of our 
study, which is a retrospective, single-center analysis with 
a limited number of cases. In addition, the disproportion 
among the groups might lead to improper conclusions. A 
prospective, randomized analysis could be the best way to 
compare two different conservative treatments, even if it is 
always difficult to apply randomization methods when a 
surgical treatment is scheduled, for each surgery should be 
tailored to the patient according to his clinical and patho-
logical characteristics, and preferences.
Conclusion 
Among the conservative treatments for penile cancer, WLE 
leads to better sexual outcomes and less postoperative com-
plications compared to glansectomy with urethral glandu-
loplasty. When feasible, WLE could represent the best con-
servative approach to treat localized primary penile cancer.
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